Ronggu Biotechnology Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$15M
- Investors
-
3
Ronggu Biotechnology General Information
Description
Developer of universal CAR-NK cell therapies designed for the treatment of hematological tumors and autoimmune diseases. The company offers cord blood-derived CAR-NK drugs, armored cell therapy platforms, and high-throughput nanobody screening software, thereby providing clinical research centers and pharmaceutical firms with specialized hardware and biological platforms for targeted immunotherapy and genetic cell engineering.
Contact Information
Website
www.rongu-bio.comCorporate Office
- Room 501, 5th Floor, Building 4
- Number 688 Bin'an Road, Changhe Street, Binjiang District
- Hangzhou, Zhejiang 310051
- China
Corporate Office
- Room 501, 5th Floor, Building 4
- Number 688 Bin'an Road, Changhe Street, Binjiang District
- Hangzhou, Zhejiang 310051
- China
Ronggu Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series A) | 06-Nov-2026 | $15M | Completed | Generating Revenue | ||
| 2. Early Stage VC | 21-Feb-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | 11-Jun-2019 | Completed | Startup |
Ronggu Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ronggu Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ronggu Biotechnology Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Changzhou Hi-tech Group | Infrastructure | Minority | ||
| Shanghai Tiliang Investment Management | Growth/Expansion | Minority | ||
| ZJKF Capital Management | Venture Capital | Minority |
Ronggu Biotechnology Investments (1)
Ronggu Biotechnology’s most recent deal was a Seed Round with Longsun Bio. The deal was made on 03-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Longsun Bio | 03-Dec-2025 | Seed Round | Biotechnology |
Ronggu Biotechnology FAQs
-
When was Ronggu Biotechnology founded?
Ronggu Biotechnology was founded in 2018.
-
Where is Ronggu Biotechnology headquartered?
Ronggu Biotechnology is headquartered in Hangzhou, China.
-
What is the size of Ronggu Biotechnology?
Ronggu Biotechnology has 16 total employees.
-
What industry is Ronggu Biotechnology in?
Ronggu Biotechnology’s primary industry is Drug Discovery.
-
Is Ronggu Biotechnology a private or public company?
Ronggu Biotechnology is a Private company.
-
What is Ronggu Biotechnology’s current revenue?
The current revenue for Ronggu Biotechnology is .
-
How much funding has Ronggu Biotechnology raised over time?
Ronggu Biotechnology has raised $15M.
-
Who are Ronggu Biotechnology’s investors?
Changzhou Hi-tech Group, Shanghai Tiliang Investment Management, and ZJKF Capital Management have invested in Ronggu Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
